News headlines about PerkinElmer (NYSE:PKI) have trended somewhat positive on Sunday, according to Accern Sentiment. Accern rates the sentiment of news coverage by analyzing more than 20 million blog and news sources in real-time. Accern ranks coverage of publicly-traded companies on a scale of negative one to positive one, with scores closest to one being the most favorable. PerkinElmer earned a media sentiment score of 0.07 on Accern’s scale. Accern also assigned headlines about the medical research company an impact score of 89 out of 100, indicating that recent news coverage is very likely to have an effect on the stock’s share price in the next several days.

These are some of the headlines that may have impacted Accern’s scoring:

Shares of PerkinElmer (PKI) traded up 0.30% during trading on Friday, reaching $69.46. The company’s stock had a trading volume of 294,190 shares. PerkinElmer has a 1-year low of $45.35 and a 1-year high of $69.52. The company’s 50-day moving average price is $64.46 and its 200 day moving average price is $57.75. The stock has a market capitalization of $7.64 billion, a price-to-earnings ratio of 36.18 and a beta of 0.76.

PerkinElmer (NYSE:PKI) last posted its earnings results on Thursday, May 4th. The medical research company reported $0.55 earnings per share for the quarter, beating the Zacks’ consensus estimate of $0.54 by $0.01. The business had revenue of $514.12 million for the quarter, compared to analysts’ expectations of $506.81 million. PerkinElmer had a net margin of 10.24% and a return on equity of 13.97%. The firm’s revenue for the quarter was up 3.2% on a year-over-year basis. During the same quarter in the previous year, the firm posted $0.50 earnings per share. Analysts anticipate that PerkinElmer will post $2.85 EPS for the current year.

The firm also recently announced a quarterly dividend, which will be paid on Thursday, August 10th. Investors of record on Friday, July 21st will be paid a $0.07 dividend. The ex-dividend date is Wednesday, July 19th. This represents a $0.28 dividend on an annualized basis and a yield of 0.40%. PerkinElmer’s payout ratio is currently 13.66%.

A number of equities analysts recently commented on PKI shares. Cowen and Company reiterated a “market perform” rating and issued a $70.00 price target (up from $61.00) on shares of PerkinElmer in a research note on Tuesday, June 20th. Jefferies Group LLC reiterated a “hold” rating and issued a $49.00 price target on shares of PerkinElmer in a research note on Monday, May 15th. Wells Fargo & Company started coverage on PerkinElmer in a research note on Thursday. They issued a “market perform” rating and a $72.00 price target for the company. BidaskClub downgraded PerkinElmer from a “strong-buy” rating to a “buy” rating in a research note on Wednesday, June 14th. Finally, Cantor Fitzgerald downgraded PerkinElmer from an “overweight” rating to a “neutral” rating and set a $60.00 price target for the company. in a research note on Wednesday, April 19th. Two research analysts have rated the stock with a sell rating, ten have given a hold rating and five have issued a buy rating to the company’s stock. The stock has an average rating of “Hold” and an average target price of $63.00.

TRADEMARK VIOLATION WARNING: This report was posted by Watch List News and is the property of of Watch List News. If you are reading this report on another site, it was copied illegally and republished in violation of United States & international copyright and trademark law. The original version of this report can be viewed at https://www.watchlistnews.com/perkinelmer-pki-receiving-somewhat-favorable-press-coverage-report-finds/1442518.html.

In other PerkinElmer news, insider Robert F. Friel sold 25,100 shares of the company’s stock in a transaction dated Thursday, May 4th. The shares were sold at an average price of $60.00, for a total transaction of $1,506,000.00. Following the sale, the insider now directly owns 597,071 shares of the company’s stock, valued at $35,824,260. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through this link. Also, insider Andrew Okun sold 4,358 shares of the company’s stock in a transaction dated Monday, June 19th. The stock was sold at an average price of $65.00, for a total transaction of $283,270.00. Following the sale, the insider now directly owns 16,799 shares in the company, valued at $1,091,935. The disclosure for this sale can be found here. In the last three months, insiders sold 170,923 shares of company stock worth $10,340,269. 2.20% of the stock is currently owned by insiders.

PerkinElmer Company Profile

PerkinElmer, Inc is a provider of products, services and solutions to the diagnostics, research, environmental, industrial and laboratory services markets. The Company operates through two segments: Discovery & Analytical Solutions and Diagnostics. The Discovery & Analytical Solutions segment serves the environmental, food, industrial, life sciences research and laboratory services markets.

Insider Buying and Selling by Quarter for PerkinElmer (NYSE:PKI)

Receive News & Ratings for PerkinElmer Inc. Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for PerkinElmer Inc. and related companies with Analyst Ratings Network's FREE daily email newsletter.